Additional variants, including MUC5B, DNAH11, ANK2, and LAMA5, which were not part of tier-1 genes but has been reported in other gastrointestinal patients (according to the Cancer Browser [25]) were also consistently detected. This evidence concerns the gene ANK2 and cancer.